MBCC 2017

Dr Serrano talks with ecancer at The Umberto Veronesi Milan Breast Cancer Conference about breast cancer prevention techniques and his aim to reduce the number of instances of the disease. He discusses the potential risk factors and looks at some preventative action that can be taken. Dr Serrano goes onto talk about the ongoing multi-centre trial looking at ER positive breast cancer and substituting low dose exemestane, a aromatase inhibitor, for tamoxifen.

Dr Garber talks with ecancer at The Umberto Veronesi Milan Breast Cancer Conference about BRCA1 and BRCA2 genes and genetic testing for hereditary breast cancers. She goes on to discuss the importance for women to consider their paternal heritage when looking into hereditary breast cancers and not only their maternal heritage.

Prof Srivastava talks with ecancer at The Umberto Veronesi Milan Breast Cancer Conference about the benefits of performing a skin and/or nipple saving mastectomy when comparing against lumpectomy & radiotherapy combinations. He discusses the higher local recurrence rate in patients receiving lumpectomy and radiotherapy compared to patients receiving a full mastectomy. Prof Srivastava goes on to outline the surgical procedure followed in the All India Institute of Medical Sciences when performing a skin sparing mastectomy.

Prof Cardoso talks to ecancer at The Umberto Veronesi Milan Breast Cancer Conference about the problems faced when facing the decision about whether to perform surgery in patients with stage 4 metastatic breast cancer at presentation. She goes on to discuss whether surgery of the primary tumour will have an impact on survival rates after bone metastasis has occurred.

Dr Veronesi talks to ecancer at The Umberto Veronesi Milan Breast Cancer Conference about the conference aims to provide caregivers and scientists interested in breast cancer with results of current research and innovations that enhance patient care and understanding of the disease.